Effect of Pantoprazole in the Treatment of Peptic Ulcer
Tang Shao
Abstract
Tang Shao
Abstract
Objective:To evaluate the effect of pantoprazole in the treatment of peptic ulcer. Method:93 patients with active peptic ulcer confirmed by endoscopy were randomly allocated to study group(group A, n=50) and control group (group B, n=43). Pantoprazole was given a dose of 40 mg po at 8 am in group A, and group B received ranitidine 300 mg p.o. at bedtime for 4 weeks. Results:①The mean time of upper abdominal pain regression for group A (4.4 days) was markedly less than that for group B(7.6 days) and the healing rate of ulcer for group A(96.0%) was significantly higher than that for group B(69.8%) with statistical differences (P0.05,P0.01).②In group A and group B, the healing rates of duodenal ulcer were 96.9% and 71.4% respectively, and gastric ulcer were 94.4% and 66.7% respectively. There were significant differences (P0.01,P0.05). Conclusion:Our data show that the effect of pantoprazole in the treatment of peptic ulcer is satisfactory, and gains an advantage over that of ranitidine.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the effect of pantoprazole in the treatment of peptic ulcer. Method:93 patients with active peptic ulcer confirmed by endoscopy were randomly allocated to study group(group A, n=50) and control group (group B, n=43). Pantoprazole was given a dose of 40 mg po at 8 am in group A, and group B received ranitidine 300 mg p.o. at bedtime for 4 weeks. Results:①The mean time of upper abdominal pain regression for group A (4.4 days) was markedly less than that for group B(7.6 days) and the healing rate of ulcer for group A(96.0%) was significantly higher than that for group B(69.8%) with statistical differences (P0.05,P0.01).②In group A and group B, the healing rates of duodenal ulcer were 96.9% and 71.4% respectively, and gastric ulcer were 94.4% and 66.7% respectively. There were significant differences (P0.01,P0.05). Conclusion:Our data show that the effect of pantoprazole in the treatment of peptic ulcer is satisfactory, and gains an advantage over that of ranitidine.
Key concepts: Pantoprazole, Ranitidine, Medicine, Gastroenterology, Internal medicine, Bedtime, Peptic ulcer, Group B